Texture analysis in 177Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture features.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 09 01 2019
accepted: 10 06 2019
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 19 2 2020
Statut: epublish

Résumé

The purpose of this study was to apply texture analysis (TA) to evaluate the uniformity of SPECT images reconstructed with the 3D Ordered Subsets Expectation Maximization (3D-OSEM) algorithm. For this purpose, a cylindrical homogeneous phantom filled with 177Lu was used and a total of 24 spherical volumes of interest (VOIs) were considered inside the phantom. The location of the VOIs was chosen in order to define two different configurations, i.e. gravity and radial configuration. The former configuration was used to investigate the uniformity of distribution of 177Lu inside the phantom, while the latter configuration was used to investigate the lack of uniformity from center towards edge of the images. For each VOI, the trend of different texture features considered as a function of 3D-OSEM updates was investigated in order to evaluate the influence of reconstruction parameters. TA was performed using CGITA software. The equality of the average texture feature trends in both spatial configurations was assumed as the null hypothesis and was tested by functional analysis of variance (fANOVA). With regard to the gravity configuration, no texture feature rejected the null hypothesis when the number of subsets increased. For the radial configuration, the statistical analysis revealed that, depending on the 3D-OSEM parameters used, a few texture features were capable of detecting the non-uniformity of 177Lu distribution inside the phantom moving from the center of the image towards its edge. Finally, cross-correlation coefficients were calculated to better identify the features that could play an important role in assessing quality assurance procedures performed on SPECT systems.

Identifiants

pubmed: 31365526
doi: 10.1371/journal.pone.0218814
pii: PONE-D-19-00773
pmc: PMC6668785
doi:

Substances chimiques

Radioisotopes 0
Lutetium 5H0DOZ21UJ
Lutetium-177 BRH40Y9V1Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0218814

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):490-499
pubmed: 27704193
EJNMMI Res. 2012 Aug 27;2(1):45
pubmed: 22925467
Med Phys. 2019 Jan;46(1):262-272
pubmed: 30418674
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Clin Radiol. 2010 Jul;65(7):517-21
pubmed: 20541651
J Nucl Med. 2012 Aug;53(8):1310-25
pubmed: 22743252
Nat Biotechnol. 2007 Jun;25(6):675-80
pubmed: 17515910
Invest Radiol. 2015 Nov;50(11):757-65
pubmed: 26115366
J Nucl Med. 2002 Oct;43(10):1343-58
pubmed: 12368373
Acta Oncol. 2017 Nov;56(11):1544-1553
pubmed: 28885084
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):618-25
pubmed: 19683403
Eur Radiol. 2012 Apr;22(4):796-802
pubmed: 22086561
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988
pubmed: 29497803
EJNMMI Phys. 2017 Dec;4(1):2
pubmed: 28063068
Eur Radiol. 2015 Oct;25(10):2840-50
pubmed: 25991476
J Nucl Med. 2016 Jan;57(1):151-62
pubmed: 26471692
Biomed Res Int. 2014;2014:248505
pubmed: 24757667
Invest Ophthalmol Vis Sci. 2011 Jul 15;52(8):5293-302
pubmed: 21613370
J Nucl Med. 2019 Jan;60(1):50-59
pubmed: 29976698
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
PLoS One. 2017 Aug 14;12(8):e0182888
pubmed: 28806773

Auteurs

Anna Sarnelli (A)

Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Emilio Mezzenga (E)

Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Alessandro Vagheggini (A)

Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Filippo Piccinini (F)

Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Giacomo Feliciani (G)

Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Maria Luisa Belli (ML)

Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Francesco Monti (F)

Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Marta Cremonesi (M)

Istituto Europeo di Oncologia, Via Ripamonti, Milano, Italy.

Corrado Cittanti (C)

Morphology, Surgery and Experimental Medicine Department, University of Ferrara, Ferrara, Italy.

Giovanni Martinelli (G)

Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Giovanni Paganelli (G)

Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forli-Cesena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH